Aditya Bardia
MBBS, MPH
Professor of Medicine
👥Biography 个人简介
Aditya Bardia at UCLA has been a principal investigator in trials of novel endocrine therapies and antibody-drug conjugates for HR-positive breast cancer. He led the EMERALD trial demonstrating elacestrant benefit in ESR1-mutant metastatic breast cancer. His research also encompasses sacituzumab govitecan and novel ADCs for HR+ disease, defining biomarker-driven treatment selection in advanced breast cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Aditya Bardia 的研究动态
Follow Aditya Bardia's research updates
留下邮箱，当我们发布与 Aditya Bardia（UCLA Jonsson Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment